Trial of an Injectable Biologic and U0279 as Combination Therapy for Severe Plaque-Type Psoriasis
This study has been withdrawn prior to enrollment.
(Business decision. No patients were enrolled)
Stiefel, a GSK Company
First Posted: January 30, 2009
Last Update Posted: April 21, 2015
Information provided by (Responsible Party):
GlaxoSmithKline ( Stiefel, a GSK Company )
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Study Status:||This study has been withdrawn prior to enrollment.|
|Estimated Study Completion Date:||April 2010|
|Estimated Primary Completion Date:||March 2010 (Final data collection date for primary outcome measure)|